Abstract
Xevinapant is a first-in-class antagonist of inhibitor of apoptosis proteins, which enhances cancer cell sensitivity to chemotherapy and radiotherapy.......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
